Home Products Most Popular Contact
No items in your cart.
The page below is a sample from the LabCE course Detection and Management of Preeclampsia: Current Laboratory Testing and Emerging Biomarkers. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Detection and Management of Preeclampsia: Current Laboratory Testing and Emerging Biomarkers (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 103 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Individual course$20 Add to cart

Treatment and Managment of Preeclampsia (PE)

Prenatal treatment options are limited due to the potential risks to the fetus. Therefore, patients with PE are simply monitored for signs and symptoms of distress. Pregnant women with mild PE are typically monitored weekly or twice weekly for blood pressure levels. In addition, select lab tests are employed to gauge potential progression to HELLP or eclampsia with possible kidney and liver involvement.
Women with severe PE are typically confined to mandatory bed rest and monitored in a manner to prevent seizures and lower their blood pressure. Antihypertensive drugs may be used for treatment of acute maternal symptoms.
Magnesium sulfate has been used to decrease the incidence of seizures in eclampsic women. Patients receiving this therapy must be monitored closely for magnesium toxicity, especially if decreased liver and kidney function are present.